Latest filing published 02 Feb 2024 for Gamida Cell Ltd..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Joshua F. Patterson: trading record in brief
Joshua F. Patterson (senior executive) discloses dealings in 2 companies, chiefly Akcea Therapeutics, Inc. and Gamida Cell Ltd. In total, 9 filings cover trades dated from 19 March 2020 to 31 January 2024.
No open-market purchase appears, only 3 sales worth €12k. Besides market trades, the filings include 5 share grants.
The record was last updated on 2 February 2024 with a share grant in Gamida Cell Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joshua F. Patterson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 480,319 shares0Ordinary SharesSEC:0001415889-24-002308:0
- 63,000 shares0Ordinary SharesSEC:0001209191-23-008564:0
- 51,000 shares0Ordinary SharesSEC:0001209191-22-005914:0
3 of 3 declarations
